Recently added
This page was added on 04 June 2018.
Updates made
This page was updated on [date-counter-updated-date]. View history of updates
Sponsor
GlaxoSmithKline Australia
Administration route
Intramuscular injection
Vaccine group
Monovalent vaccines
Description:
Registered for use from birth.
Recombinant hepatitis B vaccine
Adult formulation
Each 1.0 mL monodose vial or pre-filled syringe contains:
- 20 µg recombinant hepatitis B surface antigen (HBsAg) protein, adsorbed onto 0.5 mg aluminium as aluminium hydroxide hydrate
Paediatric formulation
Each 0.5 mL monodose vial or pre-filled syringe contains:
- 10 µg HBsAg protein, adsorbed onto 0.25 mg aluminium as aluminium hydroxide hydrate
Both formulations may contain yeast proteins.
For Product Information and Consumer Medicine Information about Engerix-B visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.
Related diseases
Page history
Last updated
Last reviewed